Matches in SemOpenAlex for { <https://semopenalex.org/work/W2536745189> ?p ?o ?g. }
- W2536745189 endingPage "5586" @default.
- W2536745189 startingPage "5579" @default.
- W2536745189 abstract "Neutralizing antibody (NAb) can dampen the immunogenicity of adenovirus (Ad) vector-based vaccine. Vector systems based on human adenovirus type 41 (Ad41) have been constructed and used to develop recombinant vaccines. Here, we attempted to study the seroprevalence of NAbs to Ad5 and Ad41 among children and adults in Qinghai province, China. The positive rates (titer⩾40) of Ad5 and Ad41 NAb in adults from Xining city were 75.7% and 94.7%, respectively. The moderate/high-positive rates (titer⩾160) of NAb were quite close between the two viruses in adults (70.4% for Ad5 and 73.5% for Ad41). Age-dependent increase of NAb seroprevalence was observed for both viruses in children. NAb-positive rate of Ad41 reached 50% at 3.3-4.6years of age for children from Chengxi district, Xining city, approximately 1.5years earlier than that of Ad5 did. Interestingly, NAb level was also associated with sanitary conditions among young children. For Ad5, 8-15% children (0.2-3.0years of age) from city or town, where the sanitations were relatively better, had moderate/high-positive NAb, while the same rate was 62% for children from villages. For Ad41, 22% children from city, 47% from town and 88% from villages possessed moderate/high-positive NAb. The possible influence of NAb titer distributions on the application of Ad41-vectored vaccines was discussed in detail. Our results suggested that children from places with poor sanitations should be included for comprehensive Ad NAb seroprevalence studies, and provided insights to the applications of Ad41 vectors." @default.
- W2536745189 created "2016-10-28" @default.
- W2536745189 creator A5008343482 @default.
- W2536745189 creator A5015855022 @default.
- W2536745189 creator A5022265757 @default.
- W2536745189 creator A5039021799 @default.
- W2536745189 creator A5039372825 @default.
- W2536745189 creator A5045624196 @default.
- W2536745189 creator A5054774521 @default.
- W2536745189 creator A5056611403 @default.
- W2536745189 creator A5078375338 @default.
- W2536745189 date "2016-11-01" @default.
- W2536745189 modified "2023-10-18" @default.
- W2536745189 title "Prevalence of serum neutralizing antibodies to adenovirus type 5 (Ad5) and 41 (Ad41) in children is associated with age and sanitary conditions" @default.
- W2536745189 cites W1517357768 @default.
- W2536745189 cites W1557780170 @default.
- W2536745189 cites W1599405074 @default.
- W2536745189 cites W1602675278 @default.
- W2536745189 cites W1821650215 @default.
- W2536745189 cites W1967846631 @default.
- W2536745189 cites W1968487372 @default.
- W2536745189 cites W1971149301 @default.
- W2536745189 cites W1971656628 @default.
- W2536745189 cites W1982361407 @default.
- W2536745189 cites W2010199399 @default.
- W2536745189 cites W2010634014 @default.
- W2536745189 cites W2017473086 @default.
- W2536745189 cites W2020246769 @default.
- W2536745189 cites W2027815800 @default.
- W2536745189 cites W2027894464 @default.
- W2536745189 cites W2031925204 @default.
- W2536745189 cites W2043373884 @default.
- W2536745189 cites W2046730970 @default.
- W2536745189 cites W2047090987 @default.
- W2536745189 cites W2047781889 @default.
- W2536745189 cites W2048927678 @default.
- W2536745189 cites W2051568749 @default.
- W2536745189 cites W2062878441 @default.
- W2536745189 cites W2065068352 @default.
- W2536745189 cites W2084340904 @default.
- W2536745189 cites W2089781867 @default.
- W2536745189 cites W2092924001 @default.
- W2536745189 cites W2109866100 @default.
- W2536745189 cites W2111108128 @default.
- W2536745189 cites W2111851565 @default.
- W2536745189 cites W2121948085 @default.
- W2536745189 cites W2122715699 @default.
- W2536745189 cites W2123857918 @default.
- W2536745189 cites W2137735834 @default.
- W2536745189 cites W2153670011 @default.
- W2536745189 cites W2159045874 @default.
- W2536745189 cites W2169962588 @default.
- W2536745189 cites W2170420667 @default.
- W2536745189 cites W2316395752 @default.
- W2536745189 cites W2357901364 @default.
- W2536745189 cites W2926509992 @default.
- W2536745189 doi "https://doi.org/10.1016/j.vaccine.2016.09.043" @default.
- W2536745189 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7115419" @default.
- W2536745189 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27682509" @default.
- W2536745189 hasPublicationYear "2016" @default.
- W2536745189 type Work @default.
- W2536745189 sameAs 2536745189 @default.
- W2536745189 citedByCount "16" @default.
- W2536745189 countsByYear W25367451892017 @default.
- W2536745189 countsByYear W25367451892018 @default.
- W2536745189 countsByYear W25367451892019 @default.
- W2536745189 countsByYear W25367451892021 @default.
- W2536745189 countsByYear W25367451892022 @default.
- W2536745189 countsByYear W25367451892023 @default.
- W2536745189 crossrefType "journal-article" @default.
- W2536745189 hasAuthorship W2536745189A5008343482 @default.
- W2536745189 hasAuthorship W2536745189A5015855022 @default.
- W2536745189 hasAuthorship W2536745189A5022265757 @default.
- W2536745189 hasAuthorship W2536745189A5039021799 @default.
- W2536745189 hasAuthorship W2536745189A5039372825 @default.
- W2536745189 hasAuthorship W2536745189A5045624196 @default.
- W2536745189 hasAuthorship W2536745189A5054774521 @default.
- W2536745189 hasAuthorship W2536745189A5056611403 @default.
- W2536745189 hasAuthorship W2536745189A5078375338 @default.
- W2536745189 hasBestOaLocation W25367451891 @default.
- W2536745189 hasConcept C104317684 @default.
- W2536745189 hasConcept C159047783 @default.
- W2536745189 hasConcept C159654299 @default.
- W2536745189 hasConcept C203014093 @default.
- W2536745189 hasConcept C2522874641 @default.
- W2536745189 hasConcept C2778494684 @default.
- W2536745189 hasConcept C2779261636 @default.
- W2536745189 hasConcept C2780868878 @default.
- W2536745189 hasConcept C32611913 @default.
- W2536745189 hasConcept C40767141 @default.
- W2536745189 hasConcept C45189115 @default.
- W2536745189 hasConcept C54355233 @default.
- W2536745189 hasConcept C71924100 @default.
- W2536745189 hasConcept C86803240 @default.
- W2536745189 hasConcept C92087593 @default.
- W2536745189 hasConceptScore W2536745189C104317684 @default.
- W2536745189 hasConceptScore W2536745189C159047783 @default.
- W2536745189 hasConceptScore W2536745189C159654299 @default.